Peripheral Blood CD4-Mediated Enhancement and CDS-Mediated Suppression in the Presence of Recombinant Hepatitis B Virus Core Antigen
- 28 February 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 161 (3) , 420-425
- https://doi.org/10.1093/infdis/161.3.420
Abstract
The proliferative response of peripheral blood T cells to hepatitis B core antigen (HBcAg) was studied in hepatitis B patients. CD4+ T cells from patients with chronic hepatitis type B (CAH-B) exhibited a significant proliferative response to HBcAg, especially in hepatitis B envelope antigen (HBeAg)-positive patients. In contrast, there was no apparent T cell reaction to HBcAg in patients with CAH non-A, non-B, HBeAg-positive healthy carriers and in healthy volunteers. The proliferative response to CD4+ cells to bacterial extracts of Escherichia coli was always insignificant in all patients and healthy volunteers. The CD8+ cells did not proliferate in response to HBcAg in any subject, even in the presence of autologous irradiated CD4+ responder cells. The CD8+ cells, preactivated with HBcAg and HBcAg-reactive irradiated autologous CD4+ cells, suppressed the proliferative response to autologous CD4+ cells to HBcAg but not the response to phytohemagglutinin in HBcAg-responder CAH-B patients. CD4-mediated HBcAg-specific enhacement and CD8-mediated HBcAg-specific suppression in the peripheral blood compartments of HBcAg-response CAH-B patients are possible.This publication has 2 references indexed in Scilit:
- CELLULAR-IMMUNITY TO THE HEPATITIS-B VIRION IN ACUTE HEPATITIS TYPE-B1983
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979